120 related articles for article (PubMed ID: 16622556)
1. [Immunohistochemistry in oligodendrogliomas].
Hilbig A; Barbosa-Coutinho LM; Netto GC; Bleil CB; Toscani NV
Arq Neuropsiquiatr; 2006 Mar; 64(1):67-71. PubMed ID: 16622556
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological study of oligodendroglioma with special reference to immunohistochemical investigation].
Kubo O; Tajika Y; Toyama T; Tajika T; Sakairi M; Katahira M; Kitamura K
No Shinkei Geka; 1988 Aug; 16(9):1029-35. PubMed ID: 2462693
[TBL] [Abstract][Full Text] [Related]
3. Nogo-a expression in glial CNS tumors: a tool to differentiate between oligodendrogliomas and other gliomas?
Kuhlmann T; Gutenberg A; Schulten HJ; Paulus W; Rohde V; Bruck W
Am J Surg Pathol; 2008 Oct; 32(10):1444-53. PubMed ID: 18685489
[TBL] [Abstract][Full Text] [Related]
4. Well-differentiated pediatric glial neoplasms with features of oligodendroglioma, angiocentric glioma and dysembryoplastic neuroepithelial tumors: a morphological diagnostic challenge.
Keser H; Barnes M; Moes G; Lee HS; Tıhan T
Turk Patoloji Derg; 2014; 30(1):23-9. PubMed ID: 24448703
[TBL] [Abstract][Full Text] [Related]
5. Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells.
Blümcke I; Becker AJ; Normann S; Hans V; Riederer BM; Krajewski S; Wiestler OD; Reifenberger G
J Neuropathol Exp Neurol; 2001 Oct; 60(10):984-93. PubMed ID: 11589429
[TBL] [Abstract][Full Text] [Related]
6. OLIG2 is a useful immunohistochemical marker in differential diagnosis of clear cell primary CNS neoplasms.
Preusser M; Budka H; Rössler K; Hainfellner JA
Histopathology; 2007 Feb; 50(3):365-70. PubMed ID: 17257132
[TBL] [Abstract][Full Text] [Related]
7. Neural antigens in oligodendrogliomas and dysembryoplastic neuroepithelial tumors.
Wolf HK; Buslei R; Blümcke I; Wiestler OD; Pietsch T
Acta Neuropathol; 1997 Nov; 94(5):436-43. PubMed ID: 9386775
[TBL] [Abstract][Full Text] [Related]
8. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.
You H; Kim YI; Im SY; Suh-Kim H; Paek SH; Park SH; Kim DG; Jung HW
J Neurooncol; 2005 Aug; 74(1):1-8. PubMed ID: 16078101
[TBL] [Abstract][Full Text] [Related]
10. Oligodendrogliomas with neurocytic differentiation. A report of 4 cases with diagnostic and histogenetic implications.
Perry A; Scheithauer BW; Macaulay RJ; Raffel C; Roth KA; Kros JM
J Neuropathol Exp Neurol; 2002 Nov; 61(11):947-55. PubMed ID: 12430711
[TBL] [Abstract][Full Text] [Related]
11. Olig2 and CD99 are useful negative markers for the diagnosis of brain tumors.
Ishizawa K; Komori T; Shimada S; Hirose T
Clin Neuropathol; 2008; 27(3):118-28. PubMed ID: 18552083
[TBL] [Abstract][Full Text] [Related]
12. So-called malignant and extra-ventricular neurocytomas: reality or wrong diagnosis? A critical review about two overdiagnosed cases.
Vallat-Decouvelaere AV; Gauchez P; Varlet P; Delisle MB; Popovic M; Boissonnet H; Gigaud M; Mikol J; Hassoun J
J Neurooncol; 2000 Jun; 48(2):161-72. PubMed ID: 11083081
[TBL] [Abstract][Full Text] [Related]
13. Myelin basic protein as a possible marker for oligodendroglioma.
Tanaka J; Hokama Y; Nakamura H
Acta Pathol Jpn; 1988 Oct; 38(10):1297-303. PubMed ID: 2464269
[TBL] [Abstract][Full Text] [Related]
14. Challenging diagnosis: oligodendroglioma versus extraventricular neurocytoma.
Mut M; Güler-Tezel G; Lopes MB; Bilginer B; Ziyal I; Ozcan OE
Clin Neuropathol; 2005; 24(5):225-9. PubMed ID: 16167546
[TBL] [Abstract][Full Text] [Related]
15. Genetic differences between neurocytoma and dysembryoplastic neuroepithelial tumor and oligodendroglial tumors.
Fujisawa H; Marukawa K; Hasegawa M; Tohma Y; Hayashi Y; Uchiyama N; Tachibana O; Yamashita J
J Neurosurg; 2002 Dec; 97(6):1350-5. PubMed ID: 12507133
[TBL] [Abstract][Full Text] [Related]
16. Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas.
Okada M; Yano H; Hirose Y; Nakayama N; Ohe N; Shinoda J; Iwama T
Brain Tumor Pathol; 2011 Apr; 28(2):157-61. PubMed ID: 21312066
[TBL] [Abstract][Full Text] [Related]
17. Olig2-positive cells in glioneuronal tumors show both glial and neuronal characters: the implication of a common progenitor cell?
Matsumura N; Yokoo H; Mao Y; Yin W; Nakazato Y
Neuropathology; 2013 Jun; 33(3):246-55. PubMed ID: 23025580
[TBL] [Abstract][Full Text] [Related]
18. [MBP and GFAP immunohistochemistry of oligodendrogliomas with relationship to myelin-forming glia in cell differentiation].
Hokama Y; Tanaka J; Nakamura H; Hori T
No To Shinkei; 1986 Apr; 38(4):379-86. PubMed ID: 2424482
[TBL] [Abstract][Full Text] [Related]
19. Neuronal nuclear antigen (NeuN): a new tool in the diagnosis of central neurocytoma.
Soylemezoglu F; Onder S; Tezel GG; Berker M
Pathol Res Pract; 2003; 199(7):463-8. PubMed ID: 14521262
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of glial fibrillary acidic protein containing cell types in oligodendrogliomas.
Kros JM; Van Eden CG; Stefanko SZ; Waayer-Van Batenburg M; van der Kwast TH
Cancer; 1990 Sep; 66(6):1204-12. PubMed ID: 2205356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
